microbiome

team layoffs workforce
Biotech

Seres shrinks head count by 25% to fund biotherapeutic's ph. 2

Seres is laying off a quarter of its workforce as the microbiome biopharma conserves resources to take its infection preventive therapy into phase 2.
James Waldron Sep 23, 2025 10:00am
Spilled martini on green background

Vedanta's live bacteria cocktail fails phase 2 colitis trial

Aug 13, 2025 1:48pm
Beneficial bacteria in gut microbiome

Fecal transplants alleviate fibromyalgia pain in small trial

Apr 28, 2025 7:30am
White mouse sticking its head through a hole in a piece of cheese

Vaccine-probiotic combo clears gut infections in mice

Apr 9, 2025 5:25am
Concepts of medical examination and study of intestine microflora

MaaT's phase 3 GvHD trial hits goal, teeing up microbiome filing

Jan 9, 2025 5:18am
C difficile clostridium difficile

Xeno's gastric-bypass pill alternative to be tested for C. diff

Jan 6, 2025 7:15am